Inventor · disambiguated record
Timothy G. Dixon
Also filed as: DIXON TIMOTHY · DIXON TIMOTHY G
8 granted patents·48 pending applications·18 citations·filing 2016–2024
79Inventor score
Top patents by PatentIndex Score
56 records- 0195US11266707B2Nutraceuticals for the prevention, inhibition, and treatment of SARS-CoV-2 and associated COVID-19ICHIM THOMAS E·Filed 2020·Granted Mar 8, 2022·8 cites·16 claims
- 0293US11229674B1Nutraceuticals for suppressing indolamine 2,3 deoxygenaseICHIM THOMAS E·Filed 2020·Granted Jan 25, 2022·7 cites·19 claims
- 0390US11504410B2Neuroprotection and neuroregeneration by pterostilbene and compositions thereofTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Granted Nov 22, 2022·2 cites·19 claims
- 0481US11759495B2Upregulation of therapeutic T regulatory cells and suppression of suicidal ideations in response to inflammation by administration of nutraceutical compositions alone or combined with minocyclineTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Granted Sep 19, 2023·1 cites·19 claims
- 0566US2024076679A1Gene silencing therapy of acute respiratory disorderTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 0664US12011462B2Stimulation of mesenchymal stem cell therapeutic activities by T regulatory cellsTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Granted Jun 18, 2024·0 cites·12 claims
- 0764US2024366677A1Aneurysm Treatment by ExosomesTHERAPEUTIC SOLUTIONS INT INC·Filed 2024·Application pending·0 cites
- 0863US2024156862A1Treatment of chronic obstructive pulmonary disease with myeloid derived suppressor cellsTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 0963US2024307446A1Generation and Utility of B Cell Subsets for Treatment of Chronic Obstructive Pulmonary DiseaseTHERAPEUTIC SOLUTIONS INT INC·Filed 2024·Application pending·0 cites
- 1063US2024034996A1Gene modified ipsc derived cellular compositions for regeneration and immune modulationTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 1163US2023226119A1Umbilical cord derived regenerative and immune modulatory stem cell populationsTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 1262US2024241119A1Prediction of stem cell therapy responsiveness by quantification of pre-existing b regulatory cellsTHERAPEUTIC SOLUTIONS INT INC·Filed 2024·Application pending·0 cites
- 1362US2024082356A1Treatment of copd by stimulation of stem cell mobilizationTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 1462US2024050485A1Treatment of chronic obstructive pulmonary disease by mesenchymal stem cell apoptotic bodies and compositions thereofTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 1561US2023301938A1Treatment of covid-19 associated cognitive dysfunction by nutraceutical preparationsTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 1661US2023364148A1Inhibition and reversion of chronic obstructive pulmonary disease (copd) by endothelial cell regenerationTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 1761US2024269148A1Enhancement of Anti-Angiogenic Cancer Immunotherapy by Abortogenic AgentsTHERAPEUTIC SOLUTIONS INT INC·Filed 2024·Application pending·0 cites
- 1860US2024226172A9Mesenchymal stem cell therapy of epilepsy and seizure disordersTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 1960US2024216472A1Enhanced efficacy of tolerogenic vaccinationTHERAPEUTIC SOLUTIONS INT INC·Filed 2024·Application pending·0 cites
- 2059US2024091269A1Treatment of bipolar disorder using mesenchymal stem cells and modification of mesenchymal stem cellsTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 2157US11951146B2Stimulation of NK cell activity by using a combination of broccoli, Nigella Sativa, Green Tea, and pterostilbene alone and together with metforminTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Granted Apr 9, 2024·0 cites·16 claims
- 2257US2022267730A1Ex vivo generation of immunocytes recognizing brother of the regulator of imprinted sites (boris) expressing cancer stem cellsTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 2357US2022306994A1Chimeric cells comprising dendritic cells and endothelial cells resembling tumor endotheliumTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 2456US2022298491A1Pluripotent stem cell derived dendritic cells and engineered dendritic cells for cancer immunotherapyTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 2556US2023047535A1Induction of neurogenesis using umbilical cord derived mesenchymal stem cells and derivatives thereofTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 2656US2023057957A1Umbilical cord mesenchymal stem cells for treatment of chronic obstructive pulmonary disease and lung degenerationTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 2756US2023277598A1Treatment of trauma associated cognitive dysfunction using mesenchymal stem cell apoptotic bodies and compositions thereofTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 2856US2022235325A1Stimulation of dendritic cell activity by homotaurine and analogues thereofTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 2955US2022370561A1Lithium as a monotherapy and/or stem cell adjuvant therapy for pulmonary fibrosisTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 3055US2023010501A1Treatment of parkinson's disease by immune modulation and regenerative meansTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 3155US2023192901A1Induction of concurrent pulmonary immune modulation and regeneration by protein mediated conjugation of immune regulatory cells with endogenous progenitor cellsTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 3254US2023085607A1Ivermectin compositions for treatment of covid-19THERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 3354US2022323547A1Amelioration and Treatment of Opioid AddictionTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 3454US2023107484A1Reduction of neutrophil extracellular trap formation by mesenchymal stem cells and their exosomesTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 3553US2022143123A1Prevention of Pathological Coagulation in COVID-19 and other Inflammatory ConditionsTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Application pending·0 cites
- 3653US2022403330A1Compositions capable of stimulating immunity towards tumor blood vesselsTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 3753US2022096542A1Augmentation of natural killer cell activity and induction of cytotoxic immunity using leukocyte lysate activated allogeneic dendritic cells: stemvacsTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Application pending·0 cites
- 3853US2022023237A1Additive and/or synergistic combinations of metformin with nutraceuticals for the prevention, inhibition and treatment of sars-cov-2 and associated covid-19THERAPEUTIC SOLUTIONS INT INC·Filed 2021·Application pending·0 cites
- 3953US2022249551A1Stimulation of natural kill cell memory by administration of dendritic cellsTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 4052US11957727B2Prevention of neuroinflammation associated memory loss using nutraceutical compositionsTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Granted Apr 16, 2024·0 cites·10 claims
- 4151US2023057356A1Enhancement of umbilical cord mesenchymal stem cell therapeutic activity by stimulators of t regulatory cells and/or cells expressing cd73THERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 4251US2022362341A1Treatment of major depressive disorder by low dose interleukin-2THERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 4351US2022370499A1Immunotherapies for targeting of tumor vasculatureTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 4451US2022280574A1Therapeutic monocytes for prevention of suicidal ideationTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 4551US2022395540A1Treatment of covid-19 lung injury using umbilical cord plasma based compositionsTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Application pending·0 cites
- 4650US9682047B2Augmentation of oncology immunotherapies by pterostilbene containing compositionsTHERAPEUTIC SOLUTIONS INT INC·Filed 2016·Granted Jun 20, 2017·0 cites·8 claims
- 4750US2022193170A1Nutraceutical Reduction Prevention and/or Reversion of Multiple SclerosisTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Application pending·0 cites
- 4850US2021128638A1Cellular, organ, and whole-body rejuvenation utilizing cord blood plasma and pterostilbeneTHERAPEUTIC SOLUTIONS INT INC·Filed 2020·Application pending·0 cites
- 4950US2022175701A1Treatment of major depressive disorder and suicidal ideations through stimulation of hippocampal neurogenesis utilizing plant-based approachesTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Application pending·0 cites
- 5049US2022193127A1Immunotherapy for opioid addictionTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Timothy G. Dixon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →